Yesterday’s Federal Court decision invalidating Pfizer’s Norvasc (amlodipine besylate) could give an early boost to Novartis’ Exforge. “Besides the generic companies that will be launching their ...

Nov. 11, 2005 — The U.S. Food and Drug Administration (FDA) has approved first-time generic formulations of glimepiride 1-, 2-, and 4-mg tablets and first-time doses of 3-, 6-, and 8-mg tablets for ...

Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...

For both hypertension and angina the usual initial dose is 5 mg amlodipine once daily which may be increased to a maximum dose of 10 mg depending on the individual patient's response. In hypertensive ...

Pfizer Wins Challenge to Norvasc Patent by Mylan Laboratories NEW YORK, Feb. 27 -- Pfizer Inc said today that a federal court in the Western District of Pennsylvania (Pittsburgh) has upheld the ...

Shares of US generic drugmaker Mylan Laboratories jumped 5.3% to $20.40 on October 4, overshooting the firm’s 52-week high on the news that final clearance from the US Food and Drug Administration to ...

A federal court jury in the Eastern District of Virginia ruled unanimously that Pfizer did not infringe Synthon IP’s US patent covering a process for making amlodipine, the active ingredient in the ...

Co announces it launched Amlodipine Besylate Tablets, 2.5 mg, 5 mg and 10 mg. Amlodipine Besylate Tablets are the generic version of Pfizer's Norvasc Tablets, which had U.S. sales of approximately ...

Unichem laboratories Limited are pleased to announce that it has received ANDA approval from the United States Food and Drug Administration (US FDA) for Amlodipine Besylate Tablets. Amlodipine ...